nutrients-logo

Journal Browser

Journal Browser

Nutrition in the Management of Short Bowel Syndrome and Intestinal Failure

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Clinical Nutrition".

Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 6454

Special Issue Editor


E-Mail Website
Guest Editor
Boston Children’s Hospital, Gastroenterology, Boston, MA 02115, USA
Interests: allergic colitis; celiac disease; constipation; crohns disease in children; diarrhea; gastroesophageal reflux disease (GERD) in children; inflammatory bowel disease (IBD) in children; intestinal atresia and stenosis

Special Issue Information

Dear Colleagues,

Intestinal failure is a condition in which an inadequate absorptive surface area or dysfunctional absorptive surface results in inadequate absorption of nutrients to sustain life. Short bowel syndrome, of which there are many causes, is perhaps the most common etiology, although several relatively rare disorders may also result in intestinal failure. The combination of parenteral and enteral nutrition must therefore be utilized in the majority of these patients to provide adequate energy and nutritional substrates. In the case of short bowel syndrome, and in certain other disorders, stimulation of intestinal adaptation through a combination of careful use of enteral nutrition and occasionally trophic drugs becomes a major goal in long-term therapy. Complications, including primarily small bowel bacterial overgrowth, but also renal and hepatobiliary stones, catheter infections, and nutritional deficiency states, must be anticipated and treated appropriately. Here again, careful use of enteral and parenteral nutrition is often key to success. In the case of failure to establish adequate adaptation and persistent intestinal failure with life-threatening complications, intestinal transplantation is often considered. Here again, both pre-and postoperatively, the use of a combination of parenteral and enteral nutrition becomes a key component of therapy. Use of appropriate nutrition to prevent nutritional deficiency states, assistance in controlling inflammation, and avoiding complications is a science unto itself. The manuscripts in this Special Edition are focused on various aspects of the specialized use of parenteral and enteral nutrition in intestinal failure both before and after intestinal transplantation.

Dr. Jon A. Vanderhoof
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Allergic colitis
  • Celiac disease
  • Constipation
  • Crohn’s disease
  • Diarrhea
  • Encopresis
  • Eosinophilic esophagitis in children
  • Food allergy
  • Gastroesophageal reflux disease (GERD)
  • Inflammatory bowel disease (IBD)
  • Short bowel syndrome
  • Intestinal atresia and stenosis
  • Stomach and duodenal ulcers
  • Abdominal pain
  • Ulcerative colitis

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 317 KiB  
Review
Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure
by Fedja A. Rochling
Nutrients 2021, 13(3), 895; https://doi.org/10.3390/nu13030895 - 10 Mar 2021
Cited by 12 | Viewed by 2888
Abstract
The development of intestinal failure-associated liver disease (IFALD) in pediatric and adult patients on parenteral nutrition is usually multifactorial in nature due to nutritional and non-nutritional causes. The role of lipid therapy as a contributing cause is well-established with the pathophysiological pathways now [...] Read more.
The development of intestinal failure-associated liver disease (IFALD) in pediatric and adult patients on parenteral nutrition is usually multifactorial in nature due to nutritional and non-nutritional causes. The role of lipid therapy as a contributing cause is well-established with the pathophysiological pathways now better understood. The review focuses on risk factors for IFALD development, biological effects of lipids, lipid emulsions and the mechanisms of lipid toxicity observed in laboratory animals followed by a synopsis of clinical studies in pediatric and adult patients. The introduction of fish oil-based lipid emulsions that provide partial or complete lipid replacement therapy has resulted in resolution of IFALD that had been associated with soybean oil-based therapy. Based on case reports and cohort studies in pediatric and adult patients who were at risk or developed overt liver disease, we now have more evidence that an early switch to partial or complete fish oil–based lipid therapy should be implemented in order to successfully halt and reverse IFALD. Full article
20 pages, 673 KiB  
Review
Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure
by Anna Rybak, Aruna Sethuraman, Kornilia Nikaki, Jutta Koeglmeier, Keith Lindley and Osvaldo Borrelli
Nutrients 2020, 12(11), 3536; https://doi.org/10.3390/nu12113536 - 18 Nov 2020
Cited by 6 | Viewed by 3257
Abstract
Gastrointestinal dysmotility is a common problem in a subgroup of children with intestinal failure (IF), including short bowel syndrome (SBS) and pediatric intestinal pseudo-obstruction (PIPO). It contributes significantly to the increased morbidity and decreased quality of life in this patient population. Impaired gastrointestinal [...] Read more.
Gastrointestinal dysmotility is a common problem in a subgroup of children with intestinal failure (IF), including short bowel syndrome (SBS) and pediatric intestinal pseudo-obstruction (PIPO). It contributes significantly to the increased morbidity and decreased quality of life in this patient population. Impaired gastrointestinal (GI) motility in IF arises from either loss of GI function due to the primary disorder (e.g., neuropathic or myopathic disorder in the PIPO syndrome) and/or a critical reduction in gut mass. Abnormalities of the anatomy, enteric hormone secretion and neural supply in IF can result in rapid transit, ineffective antegrade peristalsis, delayed gastric emptying or gastroesophageal reflux. Understanding the underlying pathophysiologic mechanism(s) of the enteric dysmotility in IF helps us to plan an appropriate diagnostic workup and apply individually tailored nutritional and pharmacological management, which might ultimately lead to an overall improvement in the quality of life and increase in enteral tolerance. In this review, we have focused on the pathogenesis of GI dysmotility in children with IF, as well as the management and treatment options. Full article
Show Figures

Figure 1

Back to TopTop